UTHealth Houston receives BRAIN Initiative grant

The National Institutes of Health has awarded a five-year, nearly $5 million grant, to establish a coordinating unit for biostatistics, informatics, and engagement to advance knowledge about the interacting neurons of the human brain. A group including UTHealth Houston, the…


Anti-inflammatory compound shows potential in treating patients with severe COVID-19

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from McGovern Medical School and other institutions. A team…


Soto receives $13 million NIH grant

A five-year, $13 million grant to study how certain infectious agents evolve to spread chronic wasting disease (CWD) has been awarded to a UTHealth Houston research team led by Claudio Soto, PhD, from the National Institutes of Health (NIH). Soto, principal investigator…


Multiple Sclerosis Patient Education Day set for April 16

The Division of Multiple Sclerosis and Neuroimmunology in the Department of Neurology will host a Patient Education Day, Saturday April 16 at the Denton A. Cooley, MD & Ralph C. Cooley, DDS University Life Center (7440 Cambridge St.). The event…


Researchers studying how special MRI protocol can help treat patients with brain hemorrhages

A study designed to determine how magnetic resonance imaging (MRI) can be used to help clinicians treat patients with brain hemorrhages is underway at McGovern Medical School at UTHealth Houston. The trial, led by Muhammad Haque, PhD, assistant professor of neurology and…


Pages